Even though melanoma was not one of the top tumor types that crosslink survival and SMG1 expression in TCGA, we chose to include this model as well to evaluate whether future pharmacological NMD inhibition could be translated onto a broader range of tumors. This evidence concerns the gene SMG1 and melanoma.